Predicting treatment failure in stage III colon cancer patients after radical surgery
Open Access
- 16 May 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1397468
Abstract
Purpose: The aim to assess treatment failure in patients with stage III colon cancer who underwent radical surgery and was analyzed using the nomogram.Methods: Clinical factors and survival outcomes for stage III colon cancer patients registered in the SEER database from 2018 to 2019 were analyzed, with patients split into training and testing cohorts (7:3 ratio). A total of 360 patients from the First Affiliated Hospital of Longyan served as an external validation cohort. Independent predictors of treatment failure were identified using logistic regression analyses. The nomograms was evaluated by concordance index (C-index), calibration curves, and the area under the curve (AUC), decision curve analysis (DCA) and clinical impact curves (CIC) assessed the clinical utility of nomograms versus TNM staging.Results: The study included 4,115 patients with stage III colon cancer. Multivariate logistic analysis age, tumor site, pT stage, pN stage, chemotherapy, pretreatment CEA levels, number of harvested lymph nodes, perineural invasion and marital status were identified as independent risk factors for treatment failure. The C-indices for the training and testing sets were 0.853 and 0.841. Validation by ROC and calibration curves confirmed the stability and reliability of the model. DCA showed that the net clinical effect of the histogram was superior to that of the TNM staging system, while CIC highlighted the potentially large clinical impact of the model.Conclusions: The developed Nomogram provides a powerful and accurate tool for clinicians to assess the risk of treatment failure after radical surgery in patients with stage III colon cancer.Keywords
This publication has 28 references indexed in Scilit:
- Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal CancerJAMA Oncology, 2024
- Association of hemicolectomy with survival in stage II colorectal cancer: a retrospective cohort studyUpdates in Surgery, 2023
- Significance of tumor deposits combined with lymph node metastasis in stage III colorectal cancer patients: a retrospective multi-center cohort study from ChinaInternational Journal of Colorectal Disease, 2022
- Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort studyEuropean Journal of Surgical Oncology, 2022
- A new prognostic and predictive tool for shared decision making in stage III colon cancerEuropean Journal of Cancer, 2020
- Subtotal colectomy, extended right hemicolectomy, left hemicolectomy, or splenic flexure colectomy for splenic flexure tumors: a network meta-analysisInternational Journal of Colorectal Disease, 2020
- Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective studyJournal of Gastroenterology, 2020
- Prognostic Value ofBRAF and KRAS Mutations in MSI and MSS Stage III Colon CancerJNCI: Journal of the National Cancer Institute, 2016
- Prognostic value of circulating tumour cells for early recurrence after resection of colorectal liver metastasesBritish Journal of Cancer, 2015
- Defining stage III disease in colorectal cancer-aspects on treatment and evaluation of survivalJournal of Surgical Oncology, 2010